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Genital C. trachomatis infections typically last for many months in women. This has been attributed to several strategies by which
C. trachomatis evades immune detection, including well-described methods by which C. trachomatis decreases the cell surface
expression of the antigen presenting molecules major histocompatibility complex (MHC) class I, MHC class II, and CD1d in
infected genital epithelial cells. We have harnessed new methods that allow for separate evaluation of infected and uninfected cells
within a mixed population of chlamydia-infected endocervical epithelial cells to demonstrate that MHC class I downregulation in
the presence of C. trachomatis is mediated by direct and indirect (soluble) factors. Such indirect mechanisms may aid in priming
surrounding cells for more rapid immune evasion upon pathogen entry and help promote unfettered spread of C. trachomatis
genital infections.
1.Introduction
Chlamydia trachomatis is an obligate intracellular bacterium
with a distinctive developmental cycle [1]. The bacteria
alternate between two forms: the metabolically inactive,
infectious elementary body (EB) and the metabolically
active, noninfectious, intracellular reticulate body (RB). EBs
infect permissive epithelial cells and diﬀerentiate into RBs
within a host-derived vacuole which is termed an inclusion.
After RBs multiply by binary ﬁssion they rediﬀerentiate into
EBs. Newly formed EBs are likely to disseminate in vivo
via direct epithelial cell rupture and release of EBs into the
extracellular milieu, or by extrusion of the intact inclusion
or dislodgement of infected cells [2–4].
The worldwide burden of C. trachomatis-associated
morbidity is great. C. trachomatis serovars A–C infect the
conjunctival epithelium and cause trachoma, the major
cause of preventable blindness worldwide [5]. C. trachomatis
serovars D–F most commonly infect the columnar epithe-
lium of the genital tract and chlamydial infection is the
most prevalent bacterial sexually transmitted infection (STI)
[6]. The endocervix is the primary point of entry, and
most commonly infected site, in the female genital tract [6].
Genital infection in women is usually asymptomatic, but can
lead to signiﬁcant morbidity including ascending infection,
pelvic inﬂammatory disease, chronic and debilitating pelvic
pain, and tubal infertility [6]. The remarkable ability of C.
trachomatis to infect the genital tract for extended periods
oftime,butcharacteristicallycauseasymptomaticinfections,
means that the pathogen goes undetected, and therefore
untreated, in many women [6]. This increases the likelihood
of secondary pathogen introduction, downstream patholog-
ical sequelae, and increased transmission to unsuspecting
sexual partners.
How C. trachomatis establishes these extended infections
is not completely understood, but this has been attributed to2 Infectious Diseases in Obstetrics and Gynecology
several immune evasion strategies employed by the pathogen
[6].Weandothershavedescribeddownregulationofantigen
presentation by C. trachomatis-infected epithelial cells as a
means of evading immune detection by both the innate
and adaptive arms of the immune response [7–11]. These
investigations were undertaken in mixed cultures of infected
and uninfected cells [7–11]. Since only a proportion of
epithelial cells will be infected by EB during any in vivo
exposure event, we hypothesized that eﬃcient and eﬀective
immuneevasionearlyintheinfectiousprocessmightinvolve
eﬀects on antigen presentation both in the cell directly
infected by the pathogen and in surrounding cells that might
be infected in subsequent rounds of infection. Here, we used
state-of-the-art methods to isolate and separately analyze C.
trachomatis-infected endocervical epithelial cells and non-
infected bystander endocervical cells that were exposed to
infected cells in the same culture. We evaluated MHC class I
surface expression in these two cell populations to determine
whether C. trachomatis-associated downregulation of MHC
class I occurs in noninfected, but exposed bystander cells.
All experiments were undertaken in the A2EN cells, a
human immortalized endocervical epithelial cell line we
recently established that retains site-appropriate expression
of key diﬀerentiation proteins and components of the innate
epithelial cell response [12].
2.MaterialsandMethods
2.1.CellCultureConditionsandC.trachomatisInfection. The
A2EN human endocervical epithelial cell line was propa-
gated in an antibiotic-free keratinocyte serum-free medium
(KSFM, Invitrogen, Carlsbad, CA, USA) supplemented with
30μg/mL recombinant epidermal growth factor (rEGF;
Invitrogen), 0.1ng/mL bovine pituitary extract (Invitrogen)
and0.4mMCaCl2 (Sigma,St.Louis,MO,USA)aspreviously
described [12]. KSFM with the supplements is referred to
here as complete KSFM (cKSFM). The cells were incubated
to grow under humidiﬁed conditions with 2% O2 and 5%
CO2 at37◦C.C.trachomatisinfections wereperformedusing
serovar D (D/UW-3/Cx) in SPG (10mM sodium phosphate
(pH 7.2), 0.25M sucrose, 5mM L-glutamic acid) at an MOI
of 1 to 3 as previously described [13]. In all experiments,
a mock-infected control was included. Immediately after
infection, SPG was removed and replaced with cKSFM alone
or with cKSFM supplemented with 30ng/mL interferon
gamma (IFNγ;P e p r o T e c h ,R o c k yH i l l ,N J ,U S A ) .C e l l sf o r
immunoﬂuorescent staining were cultured in 12-well culture
plates with coverslips. Cells for ﬂow cytometric analyses were
cultured in 6-well culture plates and harvested using a mild
cell detaching agent, Accutase (Innovative Cell Technologies,
San Diego, CA, USA) at 38 hours after infection (hpi).
2.2. Immunoﬂuorescent Staining. Mock-infected and C. tra-
chomatis-infected cells grown on coverslips were washed
with phosphate buﬀered saline (PBS) and ﬁxed with 4%
paraformaldehyde. After ﬁxation, the cells were washed and
permeabilized with 0.5% saponin. Adherent cells were then
blocked with Background Sniper blocking reagent (Biocare
Medical, Concord, CA, USA) to inhibit nonspeciﬁc staining.
To visualize the chlamydial inclusions, C. trachomatis-infec-
ted cells were stained using MeriFluor antichlamydial LPS
conjugated to ﬂuorescein isothiocyanate (Meridian Bio-
science, Inc., Cincinnati, OH, USA). DAPI (Thermo Fisher
Scientiﬁc, Rockford, IL, USA) was used to stain nucleic
acid. Stained cells were ﬁxed with Prolong Gold antifade
reagent (Invitrogen). Images of the cells were acquired at
40xmagniﬁcationusingaﬂuorescentmicroscope(Olympus,
Center Valley, PA, USA).
2.3. Flow Cytometric Analyses of C. trachomatis-Infected and
Uninfected Cells. Mock-infected A2EN cells and A2EN cells
infected with C. trachomatis at MOIs of 1, 2, and 3 were har-
vested, ﬁxed, and permeabilized using Perm/ﬁx reagent (BD
Biosciences, San Jose, CA, USA). The cells were then stained
with anti-chlamydial-LPS-FITC (Accurate, Westbury, NY,
USA) and analyzed by ﬂow cytometry. Uninfected cells were
delineatedfromC.trachomatis-infectedcellsinC.trachoma-
tis-infected cultures using the FlowJo software gating tool
(Tree Star, Inc., Ashland, OR, USA), by setting a threshold
based on the baseline ﬂuorescent intensity of unlabeled-
mock-infected controls. The percentages of infected cells
from C. trachomatis cultures infected at diﬀerent MOIs were
determined by setting the gating tool on the population
of cells with ﬂuorescence intensity above the established
threshold.
2.4. MHC Class I Expression Analysis Using Flow Cytometry.
A2ENcellsweremock-infectedorinfectedwithC.trachoma-
tis at an MOI of 2 and grown in cKSFM and or cKSFM with
30ng/mL IFN gamma for 38hpi. Cells were then harvested
using Accutase (eBioscience, San Diego, CA, USA), perme-
abilizedwithPerm/Fixreagent(BDBiosciences)anddouble-
stained with anti-chlamydial-LPS-FITC (Accurate) and anti-
MHC class-I-PE (W6/32, eBiosciences). Immunostained
cells were analyzed by ﬂow cytometry. We ﬁrst separated
uninfected cells from C. trachomatis-infected cells using a
FlowJo software gating tool based on ﬂuorescence measured
on the FL1 channel (FITC). MHC class I surface expression
levels on uninfected and C. trachomatis-infected cells were
then determined based on ﬂuorescence intensity analyzed
using the FL2 channel (PE). Results were depicted using
histograms.
2.5. Eﬀects of Cell Culture Supernatants on MHC Class I
Expression. Culture media from mock-infected and C. tra-
chomatis-infected (MOI = 2) cultures grown in the presence
or absence of 30ng/mL of IFN gamma were aspirated from
cultures at 38hpi. Harvested media were then centrifuged at
300×g and supernatants were collected and ﬁlter-sterilized
through 0.2μm ﬁlter units. Filtered supernatants were then
diluted with fresh culture media at a ratio of 1:5 and added
t of r e s hm o n o l a y e r so fA 2 E Nc e l l s .As e p a r a t ec u l t u r ei n
media alone was included as an additional negative control.
Cells were incubated for 24 hours and harvested for analysis
of MHC class I expression using ﬂow cytometry using the
methods described previously.Infectious Diseases in Obstetrics and Gynecology 3
3. Results andDiscussion
In vitro models of C. trachomatis infection can be modiﬁed
to cause ﬁrst-round infection of nearly all of the exposed
cells, but only when high C. trachomatis MOIs are used
and cyclohexamide is added to the culture, which inhibits
cell growth but also host protein synthesis. More common
infection protocols, particularly those performed in the
absence of cyclohexamide, result in a mixed population of
infected and uninfected cells. While the latter more closely
resemblesinvivoinfection[14],themixedpopulationofcells
generated through in vitro protocols is typically evaluated
in bulk. Recent advancements in ﬂow cytometric analysis of
permeabilized and intracellularly immunostained cells have
allowed separate evaluation of infected and noninfected but
exposed cells within a C. trachomatis-infected in vitro model
[15–17]. We are not aware of any reports that have harnessed
these methods to evaluate diﬀerences in the characteristics of
theresultantcellpopulations,particularlythosegrowninthe
absence of cyclohexamide.
A2EN cells are of endocervical origin and, although
immortalized, they retain the characteristics of primary
human endocervical epithelial cells through multiple pas-
sages [12, 18] and can be infected with C. trachomatis. Since
the endocervix is the primary site of C. trachomatis entry
in humans [6], A2EN cells represent a highly physiologic in
vitro cell model for the study of heterosexual transmission of
C. trachomatis.
We ﬁrst veriﬁed ﬂow cytometric separation of infected
and exposed, noninfected A2EN cells using MOI titration
experiments. A2EN cells were exposed to C. trachomatis,
serovar D, one of the 3 most common genitally trans-
mitted serovars in the United States [19]o v e rar a n g e
of MOIs to generate mixed populations of infected and
noninfected cells within a single culture. Cultures were then
permeabilized, exposed to a FITC-labeled antibody against
chlamydial lipopolysaccharide (anti-chlamydial-LPS-FITC)
and evaluated using ﬂow cytometry. Figure 1 depicts cells
exposed to C. trachomatis serovar D at an MOI of 2 and
cultured for 38hpi. The upper panel shows a group of
infected and uninfected A2EN cells stained with DAPI. The
lower panel analyzes the same cells for FITC positivity and
shows that C. trachomatis infection of A2EN cells at an MOI
of 2 results in infection of approximately 40–50% of the cells
in culture. Flow cytometric analysis of A2EN cells exposed to
C. trachomatis serovar D at an MOI of 0 (control), 1, 2, or 3
and cultured for 38hpi is shown in Figure 2.
As in Figure 1, cells were permeabilized and immunos-
tained with anti-chlamydial-LPS-FITC prior to ﬂow cytome-
try. As expected, nonexposed cells showed no FITC-positive
cells. As the C. trachomatis exposure MOI increases, the
percentage of FITC-positive cells increases from 39.8% to
55.1%. The 45.6% LPS-FITC positivity noted after infection
at an MOI of 2 conﬁrms the nonquantitative results shown
in Figure 1.
Methods that allow the distinct evaluation of C. tra-
chomatis-infected versus uninfected but exposed cells within
a single culture condition have many potential applications
to human chlamydial disease. Our interest in chlamydial
immune evasion of antigen presentation, combined with
prior reports that infection of monocytes by C. pneumonia
resulted in an IL 10-mediated downregulation of MHC class
I expression in monocytes [20] led us to hypothesize that
MHC class I downregulation in human endocervical cells
may occur through direct and bystander mechanisms.
In Figure 3, A2EN cells were mock infected or infected
withC.trachomatisserovarDatanMOIof2for38hpiinthe
presence or absence of IFNγ. Control cultures were exposed
to IFNγ alone. Cells were then permeabilized, exposed
to anti-chlamydial-LPS-FITC and to a ﬂuorescently-labeled
antibody recognizing properly folded MHC class I molecules
in association with β2-microglobiulin, and analyzed by ﬂow
cytometry. C. trachomatis-infected cells within the mixed
culture had decreased cell surface expression of MHC class
I when compared to mock-infected cells. Those infected
cells exposed to IFNγ displayed an intermediate level of
MHCclassIexpressionwhencomparedtouninfected,IFNγ-
exposed cells and to Ct r a c h o m a t i s -infected, non-IFNγ-
exposedcells.AnoninfectedculturewasexposedtoIFNγ asa
positivecontrolanddisplayedthehighestlevelofcellsurface-
expressed MHC class I molecules. Uninfected cells within
the infected cultures also displayed reduced levels of surface
MHC class I expression when compared to cells exposed to
IFNγ alone (positive control) and to mock-infected cells. In
bothIFNγ-exposedandnonexposedcultures,thedecreasein
MHC class I expression in infected cells was greater than that
in noninfected cells in the same culture.
To conﬁrm that these eﬀects were the result of soluble
mediators, uninfected A2EN cells were exposed to fresh
culture media, to media from mock-infected cells (38hpi)
and to media from cells infected by C. trachomatis serovar
D at an MOI of 2 for 38 hours in the presence and absence
of IFNγ. Cells were then immunostained for properly folded
MHC class I as above and analyzed by ﬂow cytometry
(Figure 4).
A2EN cells exposed to supernatants from noninfected,
IFNγ-exposed cells exhibited the greatest increase in MHC
classIsurfaceexpressionwhencomparedtothoseexposedto
mediaaloneortosupernatantsfrommock-infectedcontrols.
Those exposed to supernatants from C. trachomatis serovar
D-infected cells had a marked decrease in MHC class I
surface expression, conﬁrming that downregulation of MHC
class I can be mediated by a purely soluble factor.
Zhong et al. initially described immune evasion through
downregulation of antigen presentation in C. trachomatis-
infected cells in 1999 [9]. They ﬁrst reported decreased
surface expression of interferon gamma-induced MHC class
II molecules in human breast (MCF-7) and ectocervical
(HeLa) cells infected with C. trachomatis serovar L2 [9]a n d
subsequently described the downregulation of IFN gamma-
induced and constitutive expression of MHC class I using
HeLa cells and C. trachomatis serovar L2 [10]. They have
further deﬁned the mechanism of downregulation of both
MHC class I and class II expression to involve a chlamydia-
speciﬁc protease called chlamydial protease activity function
(CPAF) [8]. We have shown that CPAF is also involved
in the downregulation of surface expression of the MHC-
like lipid antigen-presenting molecule, CD1d, in human4 Infectious Diseases in Obstetrics and Gynecology
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Figure 1: C. trachomatis-infected endocervical epithelial cell (A2En) culture. The immortalized endocervical epithelial cell line A2EN was
exposed to C. trachomatis serovar D at multiplicity of infection of 2 in the absence of cyclohexamide (right two panels). This resulted in a
mixed population of infected and uninfected cells. Infected cells are stained green with chlamydial LPS conjugated to FITC, and nucleic acid
is stained with DAPI (blue). Uninfected controls are included in the left two panels for comparison. Data is representative of experiments
performed greater than 10 times.
penile urethral epithelial cells [7]. CD1d downregulation
has functional implications in that C. trachomatis serovar
F infection inhibits CD1d ligand-induced secretion of IL-
12 and IL-15, but not of IL-10 [11]. It is not surprising
that all three antigen presenting systems are aﬀected by C.
trachomatis infection, as CD4+ cells, CD8+ cells, and NKT
cells have been implicated in C. trachomatis clearance and/or
pathogenesis [6, 21–26].
Modulationofantigenpresentationinneighboringunin-
fected cells may be advantageous to chlamydial survival in
vivo. Inhibition of a nearby cell’s ability to rapidly detect
infection should widen the time frame for unfettered spread
of the infection. Our methods, which evaluate infected and
uninfected bystander cells at 38hpi, allow for the eﬀects
of soluble mediators to occur, which for proinﬂammatory
cytokines and chemokines in C. trachomatis infection are
delayed until 20–24 hours after infection [27]. We are
presently in the process of further deﬁning the host soluble
factor or alternative factors that may be responsible for
the decrease in surface expression of MHC class I among
noninfected cells in C. trachomatis serovar D-infected endo-
cervical cell cultures. We suspect there may be several factors
involved. Results on C. pneumonia-induced downregulation
of MHC class I expression in monocytes makes IL-10 a
possible candidate mediator [20] ,a n do u ro w ne x p e r i m e n t s
using penile urethral cells infected with C. trachomatis
serovar F infection suggest that IL-10 signaling may be
speciﬁcally protected during genital chlamydial infections
[11].OthershaveshownthatCXCL12stimulationofCXCR4
on HeLa cells results in MHC class I ubiquitination and
targeting to endosomal degradation [28]. Since we have
noted a stimulation of CXCR4 surface expression in A2EN
cells infected with C. trachomatis serovar D (unpublished
observations), this raises the possibility that CXCL12 might
also be another candidate mediator involved in MHC class
I downregulation in our in vitro endocervical epithelial cell
model. Rasmussen et al. [27] have shown that infection
of transformed cervical and colonic epithelial cell lines
with C. psittaci and C. trachomatis increases the secretion
of IL-8, GROα, GM-CSF, and IL-6, but only after 20–24
hours after-infection and these mediators will be studied
in conjunction with the IL-10, CXCL12, and others to
better deﬁne the mechanisms involved in MHC class I
modulationinbystandercellswithinculturesofprimary-likeInfectious Diseases in Obstetrics and Gynecology 5
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Figure 2: Separation of infected and uninfected endocervical epithelial cells in a C. trachomatis-exposed culture. Using chlamydial-LPS
ﬂuorescently labeled with FITC, infected and noninfected A2EN cell populations from the same culture can be distinguished and analyzed
independently. This separation allows for the analysis of speciﬁc host cellular responses to C. trachomatis infection in infected and in
bystander-uninfected cells. Left column shows side scatter (SSC) and chlamydial LPS-FITC dot plots, indicating a shift in granularity of
FITC positive cells. Right column shows cell number and chlamydial-LPS histograms, which reﬂect the proportion of uninfected and
C.t r a c h o m a t i s -infected cells within a pool of cells from A2En cultures exposed to varying multiplicities of infection (MOIs). Data is
representative of experiments performed greater than 10 times.
Mock-infected
Isotype
C. trachomatis-infected
Uninfected cells in C. trachomatis infected culture
100
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C. trachomatis infected + IFNγ
Uninfected cells in C. trachomatis infected culture + IFNγ
+ IFNγ
Figure 3: MHC class I surface expression on infected and uninfected bystander endocervical epithelial cells in cultures exposed to C.
trachomatis. Surface expression levels of MHC class I were assessed in the two populations of cells found in C. trachomatis-exposed cultures.
A2En cells were either mock infected (gray) or exposed to C. trachomatis at MOI of 2, with cKSFM alone (green) or cKSFM with 30 ng/mL
IFN gamma (blue). Mock-infected A2EN cells exposed to 30ng/mL IFN gamma (red) were analyzed in parallel. Isotype control is shown as
black line histogram. Surface expression of MHC class I is depicted using histograms. The green solid histogram represents C. trachomatis-
infected cells, the dashed green line represents bystander uninfected cells, the blue solid histogram represents C. trachomatis-infected cells
exposed to IFN gamma, and the blue dashed line represents uninfected cells in IFN gamma-exposed cultures. Downregulation of MHC class
I expression was observed on both the C. trachomatis-infected cells and on bystander cells. Data is representative of experiments performed
in duplicate three times.Infectious Diseases in Obstetrics and Gynecology 7
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Figure 4: Eﬀect of C. trachomatis-exposed A2EN cell culture media on MHC class I surface expression on uninfected A2EN endocervical
epithelial cells. Uninfected monolayers of A2EN cells were exposed to culture media from C. trachomatis-infected A2EN cell culture (green),
mock-infected culture (gray), IFN gamma exposed infected cell culture (blue), and fresh culture media (red). An isotype control is shown
as black line histogram. Exposure of endocervical cells to culture media from C. trachomatis-infected culture at an MOI of 2 for 38 hours,
(during which ∼50% of cells are infected with C. trachomatis) resulted in the downregulation of MHC class I expression on endocervical
epithelial cells. Data is representative of experiments performed twice in duplicate.
endocervical epithelial cells infected with genital serovars of
C. trachomatis.
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